|Leaders of INOVA, UVA, and Fairfax County announce a partnership. [INOVA]|
The institutions will collaborate on research, medical education, and the recruitment of eminent scientists to facilitate health innovation. “Together, they will put Virginia at the forefront of discovery, working to advance the science of precision medicine and improve the health of the commonwealth’s citizens,” states an Inova news release.
The two partners will collaborate on the development of a Global Genomics and Bioinformatics Research Institute located at the Inova Center for Personalized Health (ICPH).
The Institute will recruit researchers, scientists, and investigators who will engage in collaborative research focused on genomics, functional biology, bioinformatics, biologically driven engineering, precision medicine, translational research, development of targeted therapeutics, and commercialization of new discoveries.
The two entities will form a cancer research partnership between the Inova Schar Cancer Institute [under the direction of Dr. Donald Trump!] and the UVA Cancer Center and will work to achieve designation by the National Cancer Institute as a Comprehensive Cancer Center.
The agreement calls for a regional campus of the UVA School of Medicine to open at Inova, which would enable UVA medical students to complete their clerkship and post-clerkship education in Northern Virginia at Inova facilities.
UVA and Inova will also explore the creation of a “biomedical investment vehicle” to advance discovery through commercialization. Leaders from the two institutions expect to finalize a definitive agreement later this year.
“We believe that this partnership with UVA, as well as with Inova’s other partners, will drive economic growth and diversification in the region and position the commonwealth of Virginia at the forefront of healthcare, scientific and technological innovation,” said Inova Health System CEO Knox Singleton.